Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Takeda Pharmaceutical Company Limited TAK

Full chart Compare
Set alert

Price alert · TAK

All alert types
20.75 USD -0.12 (-0.57%)

At closeNov 3, 2026, 7:28 PM EST

20.75 0.00 0.00%

After hours · Nov 3, 7:28 PM ET

20.71 Day range 20.91
13.50 52-week range 21.22
YTD
+33.10%
1 year
+54.62%

Financial health

Altman Z-Score

1.38 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B+3 / 5 overall

  • DCF 4
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 2
  • P/B 4

Valuation

P/E 46.0×
FY 2016: 35.8×FY 2017: 21.7×FY 2018: 65.6×FY 2019: 115×FY 2020: 16.8×FY 2021: 23.7×FY 2022: 21.4×FY 2023: 45.0×FY 2024: 65.2×FY 2025: 46.0×
FY 2016 5y median 45.0× FY 2025
P/S 1.9×
FY 2016: 2.4×FY 2017: 2.3×FY 2018: 2.1×FY 2019: 1.5×FY 2020: 2.0×FY 2021: 1.5×FY 2022: 1.7×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.9×
FY 2016 5y median 1.6× FY 2025
P/B 1.2×
FY 2016: 2.2×FY 2017: 2.0×FY 2018: 0.9×FY 2019: 1.1×FY 2020: 1.2×FY 2021: 1.0×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 1.0×FY 2025: 1.2×
FY 2016 5y median 1.0× FY 2025
P/FCF 14.8×
FY 2016: 27.5×FY 2017: 16.2×FY 2018: 22.6×FY 2019: 11.2×FY 2020: 8.2×FY 2021: 5.8×FY 2022: 19.8×FY 2023: 27.5×FY 2024: 10.6×FY 2025: 14.8×
FY 2016 5y median 14.8× FY 2025
EV/EBITDA 9.9×
FY 2016: 16.6×FY 2017: 13.2×FY 2018: 20.3×FY 2019: 14.2×FY 2020: 10.1×FY 2021: 7.6×FY 2022: 8.3×FY 2023: 8.9×FY 2024: 9.3×FY 2025: 9.9×
FY 2016 5y median 8.9× FY 2025
EV/Sales 2.8×
FY 2016: 2.9×FY 2017: 2.7×FY 2018: 4.5×FY 2019: 2.9×FY 2020: 3.1×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 2.5×FY 2024: 2.5×FY 2025: 2.8×
FY 2016 5y median 2.5× FY 2025
FCF Yield 6.8%
FY 2016: 3.6%FY 2017: 6.2%FY 2018: 4.4%FY 2019: 8.9%FY 2020: 12.3%FY 2021: 17.2%FY 2022: 5.1%FY 2023: 3.6%FY 2024: 9.5%FY 2025: 6.8%
FY 2016 5y median 6.8% FY 2025

Profitability

Gross Margin 51.1%
FY 2016: 67.7%FY 2017: 72.0%FY 2018: 68.5%FY 2019: 66.9%FY 2020: 68.9%FY 2021: 69.0%FY 2022: 69.1%FY 2023: 66.4%FY 2024: 65.5%FY 2025: 51.1%
FY 2016 5y median 66.4% FY 2025
Operating Margin 12.0%
FY 2016: 9.0%FY 2017: 13.7%FY 2018: 9.8%FY 2019: 3.1%FY 2020: 15.9%FY 2021: 12.9%FY 2022: 12.2%FY 2023: 5.0%FY 2024: 7.5%FY 2025: 12.0%
FY 2016 5y median 12.0% FY 2025
Net Margin 4.3%
FY 2016: 6.6%FY 2017: 10.6%FY 2018: 5.2%FY 2019: 1.3%FY 2020: 11.8%FY 2021: 6.4%FY 2022: 7.9%FY 2023: 3.4%FY 2024: 2.4%FY 2025: 4.3%
FY 2016 5y median 4.3% FY 2025
ROE 2.6%
FY 2016: 6.1%FY 2017: 9.4%FY 2018: 2.1%FY 2019: 0.9%FY 2020: 7.3%FY 2021: 4.0%FY 2022: 5.0%FY 2023: 2.0%FY 2024: 1.6%FY 2025: 2.6%
FY 2016 5y median 2.6% FY 2025
ROIC 3.1%
FY 2016: 3.6%FY 2017: 6.2%FY 2018: 1.7%FY 2019: -0.7%FY 2020: 4.6%FY 2021: 3.1%FY 2022: 3.5%FY 2023: 1.6%FY 2024: 1.7%FY 2025: 3.1%
FY 2016 5y median 3.1% FY 2025
ROA 1.3%
FY 2016: 2.6%FY 2017: 4.6%FY 2018: 0.8%FY 2019: 0.3%FY 2020: 2.9%FY 2021: 1.7%FY 2022: 2.3%FY 2023: 1.0%FY 2024: 0.8%FY 2025: 1.3%
FY 2016 5y median 1.3% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2016: -4.2%FY 2017: 2.2%FY 2018: 18.5%FY 2019: 56.9%FY 2020: -2.8%FY 2021: 11.6%FY 2022: 12.8%FY 2023: 5.9%FY 2024: 7.5%FY 2025: 4.3%
FY 2016 FY 2025
Operating Income 67.3%
FY 2016: 19.1%FY 2017: 55.1%FY 2018: -15.2%FY 2019: -51.0%FY 2020: 407.2%FY 2021: -9.5%FY 2022: 6.4%FY 2023: -56.4%FY 2024: 60.0%FY 2025: 67.3%
FY 2016 FY 2025
EPS (diluted) 90.1%
FY 2016: 43.8%FY 2017: 62.4%FY 2018: -70.7%FY 2019: -59.4%FY 2020: 745.9%FY 2021: -39.0%FY 2022: 38.4%FY 2023: -54.9%FY 2024: -26.3%FY 2025: 90.1%
FY 2016 FY 2025
Free Cash Flow -7.5%
FY 2016: 351.6%FY 2017: 67.1%FY 2018: -22.1%FY 2019: 132.6%FY 2020: 71.3%FY 2021: 21.0%FY 2022: -63.3%FY 2023: -31.4%FY 2024: 187.6%FY 2025: -7.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 0.9×FY 2017: 1.5×FY 2018: 1.2×FY 2019: 1.1×FY 2020: 1.5×FY 2021: 1.2×FY 2022: 1.0×FY 2023: 1.1×FY 2024: 1.0×FY 2025: 1.3×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 0.7×
FY 2016: 0.8×FY 2017: 1.2×FY 2018: 0.8×FY 2019: 0.8×FY 2020: 1.1×FY 2021: 0.8×FY 2022: 0.6×FY 2023: 0.6×FY 2024: 0.5×FY 2025: 0.7×
FY 2016 5y median 0.6× FY 2025
Debt / Equity 0.6×
FY 2016: 0.6×FY 2017: 0.5×FY 2018: 1.1×FY 2019: 1.1×FY 2020: 0.9×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.6×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA 3.1×
FY 2016: 2.8×FY 2017: 1.9×FY 2018: 10.9×FY 2019: 6.6×FY 2020: 3.7×FY 2021: 3.0×FY 2022: 3.0×FY 2023: 3.6×FY 2024: 3.4×FY 2025: 3.1×
FY 2016 5y median 3.1× FY 2025
Interest Coverage 1.5×
FY 2016: 6.7×FY 2017: 7.6×FY 2018: 4.3×FY 2019: 68.8×FY 2020: 3.9×FY 2021: 3.8×FY 2022: 4.2×FY 2023: 201×FY 2024: 2.5×FY 2025: 1.5×
FY 2016 5y median 3.8× FY 2025

Dividends

Dividend Yield 3.4%
FY 2016: 3.4%FY 2017: 3.5%FY 2018: 3.3%FY 2019: 5.6%FY 2020: 4.5%FY 2021: 5.2%FY 2022: 4.1%FY 2023: 4.4%FY 2024: 4.2%FY 2025: 3.4%
FY 2016 5y median 4.2% FY 2025
Payout Ratio 153.4%
FY 2016: 123.3%FY 2017: 75.9%FY 2018: 131.0%FY 2019: 638.7%FY 2020: 75.4%FY 2021: 123.3%FY 2022: 88.1%FY 2023: 199.3%FY 2024: 280.3%FY 2025: 153.4%
FY 2016 5y median 153.4% FY 2025

Annual · latest fiscal year ends 2026-03-31